Old Web
English
Sign In
Acemap
>
authorDetail
>
Henning De May
Henning De May
University of New Mexico
Cancer research
Ovarian cancer
CD49d
Pathology
Immune checkpoint
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns
2021
Nature Biomedical Engineering
Jimin Guo
Henning De May
Stefan Franco
Achraf Noureddine
Lien Tang
C.J. Brinker
Donna F. Kusewitt
Sarah Adams
Rita E. Serda
Show All
Source
Cite
Save
Citations (1)
CD49d (high) T cells in the ovarian cancer microenvironment are a potential target for the optimization of immune checkpoint therapy in ovarian cancer.
2019
Journal of Clinical Oncology
Henning De May
Sharina Palencia Desai
Ichiko Kinjyo
Jaryse Harris
Sarah Adams
Show All
Source
Cite
Save
Citations (1)
1